期刊文献+

睑板腺功能障碍与睑板腺脂质改变 被引量:10

Changes in human meibum with meibomian gland dysfunction
原文传递
导出
摘要 睑板腺功能障碍(MGD)是临床常见的眼表疾病,以睑板腺终末导管阻塞和(或)睑板腺分泌物的质量和数量改变为特征.睑板腺脂质是由多种脂质组成的混合物,其构成了泪膜的脂质层,具有防止水分蒸发,维持泪膜稳定性的作用.MGD时,睑板腺脂质的成分将发生相应改变,是诊断MGD的重要指标.目前用于分析睑板腺脂质的主要方法包括色谱法和光谱法,但均不理想.由于MGD的病因尚不明确,故临床治疗方式以对症治疗为主.简便有效分析睑板腺脂质的质量和数量,将有助于临床诊断和治疗MGD. Meibomian gland dysfunction (MGD) is a common ocular surface disease,characterized by terminal duct obstruction and (or) qualitative and quantitative changes in the glandular secretion.Meibomian lipids are a mixture consisting of various lipids,and they form the lipid layer of tear film and play important roles in preventing the evaporation and maintaining the stability of tear film.Patients with MGD may have different compositions of meibomian lipids,which could be an important indicator for diagnosis of MGD.The methods to analyze the composition of meibomian lipids mainly include chromatography and spectrum analysis.Because the pathogenic factors of MGD are still unclear,the main treatment is to relieve the symptoms.It can contribute to diagnose and treat MGD if we can find some convenient and effective methods to analyze the quality and quantity of meibomian lipids.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2015年第3期225-228,共4页 Chinese Journal of Ophthalmology
关键词 睑板腺 眼睑疾病 脂类 色谱法 光谱分析 Meibomian glands Eyelid diseases Lipids Chromatography Spectrum Analysis
  • 相关文献

参考文献25

  • 1乔静,晏晓明.睑板腺脂质研究进展[J].中华眼科杂志,2012,48(12):1141-1145. 被引量:23
  • 2Knop E, Knop N, Millar T, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland [J]. Invest Ophthalnlol Vis Sci, 2011, 52(4) : 1938-1978.
  • 3Nicolaides N, Kaitaranta JK, Rawdah TN, et al. Meibomian gland studies: comparison of steer and human lipids [J]. Invest Ophthalmol Vis Sci, 1981, 20(4) : 522-536.
  • 4Joffre C, Southier M, Grgoire S, et al. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous deficient dry eye [ J ]. Br J Ophthalmol,2008, 92(1) : 116-119.
  • 5McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function[ J]. Exp Eye Res, 2004, 78(3) : 361- 365.
  • 6Bron AJ, Tiffany JM. The meibomian glands and tear film lipids. Structure, function, and control[J]. Adv Exp Med Biol, 1998, 438 : 281-295.
  • 7Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The International Workshop on Meibomian Gland Dysfunction: report of the definition and classification subcommittee [ J ]. Invest Ophthalmol Vis Sci, 2011, 52(4) : 1930-1937.
  • 8Shimazaki J, Sakata M, Tsubota K, et al. Ocular surface changes and discomfort in patients with meibomian gland dysfunction [ J ]. Arch Ophthalmol, 1995, 113 (10) : 1266-1270.
  • 9Driver H, Lemp MA. Meibomian gland dysfunction [ J ]. Surv Ophthalmol, 1996, 40(5) : 343-367.
  • 10Bron A J, Tiffany JM. The contribution of meibonfian disease to dry eye[J]. Oeul Surf, 2004, 2(2) : 149-165.

二级参考文献78

  • 1赵晓彬,晏晓明.非甾体类抗炎剂滴眼液与角膜融解[J].国际眼科纵览,2006,30(6):394-397. 被引量:9
  • 2蔡望,唐仁泓.准分子激光原位角膜磨镶术后干眼症的临床分析[J].医学临床研究,2007,24(3):370-372. 被引量:7
  • 3Avunduk AM,Avunduk MC,Varnell ED,Kaufman HE.The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients:a clinical and immunocytochemical study[J].Am J Ophthalmol,2003,136(4):593-602.
  • 4Nagelhout TJ,Gamache DA,Roberts L,Brady MT,Yanni JM.Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye[J].J Ocul Pharmacol Ther,2005,21(2):139-148.
  • 5Stern ME,Beuerman RW,Fox RI,Mircheff AK,Pflugfelder SC.The pathology of dry eye:the interaction betw een the ocular surface and lacrimal glands[J].Cornea,1998,17(6):584-589.
  • 6Hsu JK,Johnston WT,Read RW,McDonnell PJ,Pangalinan R,Rao N,et al.Histopathology of corneal melting associated w ith diclofenac use after refractive surgery[J].J Cataract Refract Surg,2003,29(2):250-256.
  • 7Driver PJ, Lemp MA. Seborrhea and meibomian gland dysfunction. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea: Fundamentals, Diagnosis and Management. Philadelphia: Elsevier Mosby, 2005 : 485-491.
  • 8McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea, 2000, 19: 650-658.
  • 9Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf, 2003, 1 : 107-126.
  • 10Goto E, Shimazaki J, Monden Y, et al. Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology, 2002, 109: 2030-2035.

共引文献53

同被引文献81

引证文献10

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部